A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet

被引：0
|
作者：
Björn Stollenwerk
Sergio Iannazzo
Ron Akehurst
Michael Adena
Andrew Briggs
Bastian Dehmel
Patrick Parfrey
Vasily Belozeroff
机构：
[1] Amgen Europe (GmbH),Health Economics and Health Technology Assessment
[2] Helmholtz Zentrum München,undefined
[3] SIHS Health Economics Consulting,undefined
[4] BresMed,undefined
[5] University of Sheffield,undefined
[6] Datalytics Pty Ltd,undefined
[7] University of Glasgow,undefined
[8] Amgen Inc.,undefined
[9] Memorial University,undefined
来源：
PharmacoEconomics | 2018年 / 36卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：603 / 612
页数：9
相关论文
共 50 条
  • [1] A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet
    Stollenwerk, Bjorn
    Iannazzo, Sergio
    Akehurst, Ron
    Adena, Michael
    Briggs, Andrew
    Dehmel, Bastian
    Parfrey, Patrick
    Belozeroff, Vasily
    [J]. PHARMACOECONOMICS, 2018, 36 (05) : 603 - 612
  • [2] Imaging strategies in children with suspected craniosynostosis: A decision-analytic model to assess cost-effectiveness
    Medina, LS
    Richardson, RR
    [J]. RADIOLOGY, 2000, 217 : 485 - 485
  • [3] Imaging and treatment of patients with suspected liver metastases: A decision-analytic model to assess cost-effectiveness
    Gazelle, GS
    Kuntz, KM
    Halpern, EF
    Lester, JS
    Hunink, MG
    Weinstein, MC
    [J]. RADIOLOGY, 1999, 213P : 243 - 243
  • [4] Imaging and treatment of patients with suspected liver metastases: A decision-analytic model to assess cost-effectiveness
    Gazelle, GS
    Kuntz, KM
    Halpern, EF
    Lester, JS
    Hunink, MG
    Weinstein, MC
    [J]. RADIOLOGY, 1999, 213P : 305 - 305
  • [5] Rf ablation vs hepatic resection in patients with suspected CRC liver metastases: A decision-analytic model to assess cost-effectiveness
    Gazelle, GS
    Lester, JS
    Goldberg, SN
    Halpern, EF
    [J]. RADIOLOGY, 2002, 225 : 488 - 488
  • [6] Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
    Ramos, G. Feljandro P.
    van Asselt, Antoinette D. I.
    Kuiper, Sandra
    Severens, Johan L.
    Maas, Tanja
    Dompeling, Edward
    Knottnerus, J. Andre
    van Schayck, Onno C. P.
    [J]. EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 (08): : 869 - 883
  • [7] Cost-effectiveness of abciximab after coronary stenting: A decision-analytic model
    Rodriguez, O
    Cutlip, DE
    Kuntz, RE
    Cohen, DJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 51A - 51A
  • [8] COST-EFFECTIVENESS OF TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION: A DECISION-ANALYTIC MODEL
    Amin, Amit P.
    Marso, Steven P.
    Chhatriwalla, Adnan
    Safley, David
    Kennedy, Kevin
    House, John
    Mills, Rebecca
    Salisbury, Adam
    Spertus, John
    Cohen, David
    Baklanov, Dmitri
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E338 - E338
  • [9] COST-EFFECTIVENESS OF MATERNAL TOXOPLASMA SCREENING IN AUSTRIA: A DECISION-ANALYTIC MODEL
    Prusa, A. R.
    Walter, E.
    Pollak, A.
    Hayde, M.
    Kasper, D. C.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A333 - A333
  • [10] Cost-effectiveness of primary prevention of paediatric asthma: a decision-analytic model
    G. Feljandro P. Ramos
    Antoinette D. I. van Asselt
    Sandra Kuiper
    Johan L. Severens
    Tanja Maas
    Edward Dompeling
    J. André Knottnerus
    Onno C. P. van Schayck
    [J]. The European Journal of Health Economics, 2014, 15 : 869 - 883
12345